World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
102
Citations
52357
World Ranking
7529
National Ranking
103

Emanuele Zucca publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Emanuele Zucca sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 713 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Emanuele Zucca D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Emanuele Zucca sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Emanuele Zucca is affiliated with the Universita della Svizzera Italiana in Switzerland. Their research primarily focuses on medical fields with an emphasis on pathology, oncology, and genetics. Zucca has contributed extensively to the study of lymphoma and related hematological malignancies.

The main fields of study associated with Zucca include Medicine, with a significant number of publications in subfields such as Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

Their work covers a range of topics strongly related to lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, and central nervous system lymphoma diagnosis and treatment. Additional topics include viral-associated cancers and disorders, CAR-T cell therapy research, radiomics and machine learning in medical imaging, and lung cancer treatments and mutations.

Frequent co-authors collaborating with Zucca include:

  • Davide Rossi
  • Francesco Bertoni
  • Anastasios Stathis
  • Luca Ceriani
  • Luciano Cascione

Zucca has published regularly in several key venues relevant to hematology and oncology research. Frequent publication venues include:

  • Hematological Oncology
  • Blood
  • Blood Advances
  • Haematologica
  • bioRxiv (Cold Spring Harbor Laboratory)

Among their recent papers are:

  • "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" (2020), published in Annals of Oncology
  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee" (2022), published in Blood
  • "Genomic profiling for clinical decision making in lymphoid neoplasms" (2022), published in Blood
  • "Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial" (2022), published in Leukemia
  • "International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia" (2020), published in Blood

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Bruce D. Cheson;Richard I. Fisher;Sally F. Barrington;Franco Cavalli

  • Follicular lymphoma international prognostic index.

    Philippe Solal-Céligny;Pascal Roy;Philippe Colombat;Josephine White

  • Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

    Sally F. Barrington;N. George Mikhaeel;Lale Kostakoglu;Michel Meignan

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

    Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli

  • Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

    Andrés J. M. Ferreri;Elías Campo;John F. Seymour;Rein Willemze

  • Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

    Emanuele Zucca;Annarita Conconi;Ennio Pedrinis;Sergio Cortelazzo

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

    Andrés J M Ferreri;Kate Cwynarski;Elisa Pulczynski;Maurilio Ponzoni

  • Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

    Michele Ghielmini;Shu Fang Hsu Schmitz;Sergio B. Cogliatti;Gabriella Pichert

  • Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

    E. Zucca;A. Conconi;T.I. Mughal;A.H. Sarris

  • Eradication of Helicobacter pylori Infection in Primary Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue

    Enrico Roggero;Emanuele Zucca;Graziella Pinotti;Anna Pascarella

  • Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas

    E. Zucca;E. Roggero;F. Bertoni;F. Cavalli

  • Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

    Maurilio Ponzoni;Andrés J.M. Ferreri;Elías Campo;Fabio Facchetti

  • Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

    Annarita Conconi;Giovanni Martinelli;Catherine Thiéblemont;Andrés J M Ferreri

  • Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    Sandy Amorim;Anastasios Stathis;Mary Gleeson;Sunil Iyengar

  • Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Anastasios Stathis;Emanuele Zucca;Mohamed Bekradda;Carlos Gomez-Roca

  • The gastric marginal zone B-cell lymphoma of MALT type

    Emanuele Zucca;Francesco Bertoni;Enrico Roggero;Franco Cavalli

  • Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Andres J. M. Ferreri;Kate Cwynarski;Elisa Pulczynski;Christopher P. Fox

Frequent Co-Authors

Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Davide Rossi
Davide Rossi European Society for Medical Oncology
Giovanni Martinelli
Giovanni Martinelli University of Bologna
Valter Gattei
Valter Gattei University of Trieste
Giorgio Inghirami
Giorgio Inghirami Cornell University
Stefano Pileri
Stefano Pileri European Institute of Oncology
Peter Johnson
Peter Johnson University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine doesn’t always mean going to medical school. There are many online degrees and alternative career pathways in healthcare that offer rewarding opportunities. For example, individuals seeking leadership roles might pursue an accelerated healthcare administration degree, which prepares graduates to efficiently run healthcare organizations.

For registered nurses aiming to advance their practice, completing an rn to np program can provide a fast track toward becoming a Nurse Practitioner. This pathway enables nurses to take on greater responsibilities and improve patient care.

Those interested in wellness and preventive care may explore the best online nutrition programs to build a strong foundation in nutritional science and expand their career options across clinical, community, and industry settings.

When choosing your path, it’s important to look for which online healthcare degree programs are recognized for their accreditation by cahme? This ensures that your degree is respected and valued by employers nationwide.

Best Scientists Citing Emanuele Zucca

Trending Scientists

Recently Published Articles